Lubrijoint OD Tablet

Tablet
Rs.562for 1 bottle(s) (30 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Lubrijoint 1500mg Tablet

Glucosamine Sulfate Potassium Chloride(1500mg)

food interaction for Lubrijoint Tablet

alcohol interaction for Lubrijoint Tablet

pregnancy interaction for Lubrijoint Tablet

lactation interaction for Lubrijoint Tablet

food
alcohol
pregnancy
lactation
Lubrijoint OD Tablet may be taken with or without food, but it is better to take it at a fixed time.
None
CAUTION
Caution is advised when consuming alcohol with Lubrijoint OD Tablet. Please consult your doctor.
CAUTION
Information regarding the use of Lubrijoint OD Tablet during pregnancy is not available. Please consult your doctor.
CONSULT YOUR DOCTOR
Information regarding the use of Lubrijoint OD Tablet during breastfeeding is not available. Please consult your doctor.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Lubrijoint 1500mg Tablet

Glucosamine Sulfate Potassium Chloride(1500mg)

Lubrijoint tablet uses

{med_name} is used in osteoarthritis.

How lubrijoint tablet works

Lubrijoint OD Tablet is a proteoglycan synthesis stimulator. It works by building cartilage (soft connective tissue around the joints) leading to joint repair. It also lowers pain and inflammation (swelling).

Common side effects of lubrijoint tablet

No common side effects seen

SUBSTITUTES FOR Lubrijoint Tablet

1 Substitutes
1 Substitutes
Sorted By
RelevancePrice
  • Navigen-OD Tablet
    (10 tablets in strip)
    Rs. 22.20/Tablet
    Tablet
    Rs. 233.40
    pay 19% more per Tablet

Expert advice FOR Lubrijoint Tablet

  • Glucosamine Sulfate Potassium Chloride is used in the treatment of osteoarthritis.
  • Inform your doctor if you have a history of being allergic to shellfish or to glucosamine.
  • You will be asked to monitor your blood glucose level while taking Glucosamine Sulfate Potassium Chloride.
  • Inform your doctor if you are taking any blood thinners like warfarin or if you have any scheduled surgery.
  • Let your doctor know if you are pregnant or breastfeeding.

Frequently asked questions FOR Lubrijoint 1500mg Tablet

Glucosamine Sulfate Potassium Chloride

Q. What is Lubrijoint OD Tablet used for?
Lubrijoint OD Tablet is used to help relieve symptoms of mild to moderate osteoarthritis of the knee. It helps improve joint comfort over time. It usually takes several weeks before people notice the benefit.
Q. Who should not take Lubrijoint OD Tablet?
Individuals should not take Lubrijoint OD Tablet if they are allergic to glucosamine, any excipient, or shellfish.
Q. Can Lubrijoint OD Tablet affect my blood sugar if I have diabetes?
People with diabetes should be cautious because Lubrijoint OD Tablet can require closer monitoring of blood sugar and insulin when treatment starts. Your doctor may check your glucose more frequently.
Show More
Q. What serious problems should make me stop Lubrijoint OD Tablet and call my doctor?
Stop Lubrijoint OD Tablet and seek medical advice if you develop signs of an allergic reaction, a sudden worsening of asthma, unexplained severe stomach symptoms, jaundice (yellow skin/eyes), or any new, serious symptoms that your doctor has warned you about.
Q. Are there people who need extra monitoring while taking Lubrijoint OD Tablet?
Yes, people with diabetes, patients on blood thinners (vitamin K antagonists), those with reduced kidney function, and people with high cholesterol and asthma should be monitored more closely while taking Lubrijoint OD Tablet.
Q. Can Lubrijoint OD Tablet make my cholesterol go up?
There have been rare reports of raised cholesterol in people taking Lubrijoint OD Tablet. It is sensible to check and monitor cholesterol if your doctor advises it.
Q. When can I expect relief after taking Lubrijoint OD Tablet, and when should treatment be re-evaluated?
Relief, especially pain reduction, may take several weeks and sometimes longer. If you do not feel a benefit after 2 to 3 months, your doctor should re-evaluate whether to continue treatment.

Content on this page was last updated on 27 September, 2025, by Dr. Sachin Gupta (MD Pharmacology, MBBS)